Scripps Research Institute Jun 19 2025 In the quest to develop an effective HIV vaccine, scientists from Scripps Research have made a significant leap forward. They found that a two-part delivery strategy can train the immune system to produce a stronger response to HIV, offering new hope in the fight against one of the world's most elusive viruses. The approach, described in Science Translational Medicine on June 18, 2025, used a mouse model to test two types of adjuvants: immune-boosting